Semaglutide vs Liraglutide

Comparing two GLP-1 medications used for weight loss and diabetes management

Explore Semaglutide

Quick Summary

Key Insight: Both Semaglutide and Liraglutide are GLP-1 receptor agonists, but Semaglutide is newer, longer-acting, and generally more effective for weight loss.

Liraglutide was an earlier GLP-1 medication requiring daily injections, while Semaglutide offers once-weekly dosing with stronger clinical weight loss outcomes.

Semaglutide Treatment (Recommended GLP-1 Option)

Semaglutide is currently considered the most effective GLP-1 medication for medical weight loss programs.

View Semaglutide Guide

Side-by-Side Comparison

Feature Semaglutide Liraglutide
Drug Class GLP-1 receptor agonist GLP-1 receptor agonist
Weight Loss 10–15% average 5–8% average
Dosing Once weekly Daily injection
Duration Long-acting Shorter-acting
Effect on Appetite Stronger suppression Moderate suppression
Cost Moderate–high Moderate
Clinical Preference Preferred in modern guidelines Older GLP-1 option

Medical Verdict

Semaglutide is generally considered a superior GLP-1 medication compared to Liraglutide due to stronger weight loss outcomes and less frequent dosing.

Liraglutide remains a valid option but is less commonly used in modern weight management protocols.

Start with Semaglutide

Most modern GLP-1 weight loss programs now prioritize Semaglutide over older GLP-1 therapies.

Dosage Guide Side Effects

FAQ

Semaglutide is generally more effective for weight loss and requires less frequent dosing.

It has a longer half-life, stronger receptor activity, and better appetite suppression.

Not outdated, but it is an older GLP-1 option with lower average effectiveness.

Semaglutide Treatment Guides